Enzyme

About:

Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance.

Website: https://www.enzyme.com

Twitter/X: enzymecorp

Top Investors: Hack VC, Y Combinator, Soma Capital, DCVC, Refactor

Description:

Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance. Using Enzyme’s software, those companies can avoid spending money on costly consultants which in turn can reduce their compliance costs by up to 50 percent. Since 10 percent of all personnel in biopharma and life sciences companies are related to regulatory issues, it can lower headcount as well. Perhaps most importantly, Enzyme can also make it easier and faster for those companies to bring their products to market.